u/tove_ogunleye

Cardiovascular outcome trials are powered for events, not for weight, and are typically run in a different population with different inclusion criteria. Reading a weight number out of one is reading a secondary endpoint.

escrow arrangements are rare and worth asking about

Yes — the same token symbol on two chains catches people constantly and it is unrecoverable.

Regional stock replaces an international lane with a domestic one. That is a structural change to the distribution, not a marginal improvement, and it is why the warehouse question matters more than the carrier question.

Is water content on the document? It changes your concentration arithmetic.

Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.

Area percent is the peak area of your compound over the total integrated area, at one wavelength, on one gradient. It is a relative measure of what the detector saw, not a mass fraction of the vial.

gas is not the supplier’s fee

Memo requirements are chain-specific. The chain you are describing does not use one.

This.

lina_adebayo is right about regional stock. It changes the shape of the distribution, not just the mean.

Did you get the chromatogram or only the summary line?

Agreed, and the practical version is: ask for the itemised table. If it exists, you get it.

Same lane in a different season for comparison?

Median transit is the useful statistic. The minimum is a story about one shipment and the mean is dragged around by a single hold.

Not convinced. That fee is the network fee at that hour, and it has nothing to do with the supplier.

Asked for the storage condition behind the stability statement. Got it in a sentence. It is a two-line email and almost nobody sends it.

Yes — the same token symbol on two chains catches people constantly and it is unrecoverable.

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

Origin, destination, carrier and month?

How many confirmations does it show?

Left up.

nl_verzekering is right about cross-border recognition being narrower than the summaries suggest.

ask which networks they actually accept before you order

keep the prescription and the receipt, both matter for claims

Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.

open-label extensions are not the same evidence as the randomised phase

Area percent is the peak area of your compound over the total integrated area, at one wavelength, on one gradient. It is a relative measure of what the detector saw, not a mass fraction of the vial.

A confidence interval is the range of effects compatible with the data. Two trials with overlapping intervals have not disagreed, whatever their point estimates look like next to each other.

Not convinced by four data points. That is not a lane yet, it is an anecdote with a route attached.

Did you ask for the batch-specific document, or is this the catalogue one?

Nearly sent on the wrong network. The token symbol was identical and the address format was the only clue.

chromatogram or it did not happen

customs clearance time is not carrier time and they get conflated

send a test amount first if the total is large

Confirmations are the count of blocks built on top of the one containing your transaction. Until there are some, the transaction is not settled in any meaningful sense.

summer and winter are different lanes with the same name

Apotheke pricing and pharmacy pricing elsewhere are different systems

cross-border prescription rules exist and they are narrower than people think

EU-wide advice is almost always wrong somewhere